Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

PharmaCyte Biotech, Inc. PMCB

Set alert

Price alert · PMCB

All alert types
0.34 USD +0.02 +6.35%

As of Nov 3, 12:48 PM ET

Bid
0.32 × 1
Ask
0.37 × 2
0.3164 Day range 0.335
0.3021 52-week range 1.51
YTD
-53.73%
1 year
-63.48%
Open
0.3164
Prev close
0.315
Mkt cap
3.60M
Vol
6.90K
Avg vol
183.73K
EPS
-2.31
P/E
0.00
Div yield
0.00%
More statistics
Low
0.3164
High
0.335
Forward P/E
-4.21
Beta
-0.20
Short ratio
1.09
Inst. own
13.16%
Dividend
0.00
Ex-div date
50-d avg
1.73
200-d avg
1.94
1y target
0.00

3M chart

Chart tools
Interval
1m5m15m30m

Signals (20)
NameDateAgo
MACD: Buy SignalNov 3, 20264 hours ago
MACD: Sell SignalOct 30, 20264 days ago
RSI: OversoldOct 30, 20264 days ago
MACD: Buy SignalOct 23, 20261 week ago
MACD: Sell SignalOct 13, 20263 weeks ago
MACD: Buy SignalSep 21, 20261 month ago
MACD: Sell SignalSep 10, 20261 month ago
RSI: OversoldSep 9, 20261 month ago
MACD: Buy SignalSep 8, 20261 month ago
MACD: Sell SignalSep 2, 20262 months ago
RSI: OversoldSep 1, 20262 months ago
MACD: Buy SignalAug 21, 20262 months ago
MACD: Sell SignalAug 20, 20262 months ago
RSI: OversoldAug 20, 20262 months ago
MACD: Buy SignalAug 19, 20262 months ago
MACD: Sell SignalAug 18, 20262 months ago
RSI: OversoldAug 18, 20262 months ago
MACD: Buy SignalAug 13, 20262 months ago
MACD: Sell SignalAug 12, 20262 months ago
MACD: Buy SignalAug 5, 20263 months ago

Financial health

Altman Z-Score

-3.39 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.3×
FY 2017: -14.4×FY 2018: -7.9×FY 2019: -11.5×FY 2020: -9.0×FY 2021: -11.2×FY 2022: -8.6×FY 2023: -13.3×FY 2024: -1.2×FY 2025: 0.4×FY 2026: -0.3×
FY 2017 5y median -1.2× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 0.2×
FY 2017: 4.2×FY 2018: 6.6×FY 2019: 9.2×FY 2020: 6.7×FY 2021: 5.9×FY 2022: 0.4×FY 2023: 0.8×FY 2024: 0.0×FY 2025: 0.2×FY 2026: 0.2×
FY 2017 5y median 0.2× FY 2026
P/FCF -1.0×
FY 2017: -10.1×FY 2018: -7.5×FY 2019: -16.2×FY 2020: -14.7×FY 2021: -11.9×FY 2022: -8.8×FY 2023: -15.0×FY 2024: -0.2×FY 2025: -3.1×FY 2026: -1.0×
FY 2017 5y median -3.1× FY 2026
EV/EBITDA 2.6×
FY 2017: 206929×FY 2018: -5.3×FY 2019: -11.2×FY 2020: -8.7×FY 2021: -10.6×FY 2022: 11.6×FY 2023: 1.7×FY 2024: 7.6×FY 2025: 1.4×FY 2026: 2.6×
FY 2017 5y median 2.6× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -101.8%
FY 2017: -9.9%FY 2018: -13.3%FY 2019: -6.2%FY 2020: -6.8%FY 2021: -8.4%FY 2022: -11.4%FY 2023: -6.7%FY 2024: -548.6%FY 2025: -32.8%FY 2026: -101.8%
FY 2017 5y median -32.8% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -58.3%
FY 2017: -55.0%FY 2018: -118.4%FY 2019: -80.7%FY 2020: -75.2%FY 2021: -53.2%FY 2022: -4.7%FY 2023: -5.9%FY 2024: 0.8%FY 2025: 59.1%FY 2026: -58.3%
FY 2017 5y median -4.7% FY 2026
ROIC -14.9%
FY 2017: -54.9%FY 2018: -121.0%FY 2019: -81.4%FY 2020: -74.1%FY 2021: -54.2%FY 2022: -4.9%FY 2023: -8.9%FY 2024: -16.2%FY 2025: -8.4%FY 2026: -14.9%
FY 2017 5y median -8.9% FY 2026
ROA -41.5%
FY 2017: -51.3%FY 2018: -106.5%FY 2019: -70.3%FY 2020: -62.1%FY 2021: -48.0%FY 2022: -4.7%FY 2023: -5.9%FY 2024: 0.6%FY 2025: 55.6%FY 2026: -41.5%
FY 2017 5y median -4.7% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income -56.6%
FY 2017: 26.9%FY 2018: -57.2%FY 2019: 41.3%FY 2020: 6.7%FY 2021: 5.3%FY 2022: -21.2%FY 2023: -47.0%FY 2024: -32.0%FY 2025: 48.6%FY 2026: -56.6%
FY 2017 FY 2026
EPS (diluted) -186.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 63.0%FY 2020: 23.8%FY 2021: 42.1%FY 2022: 89.0%FY 2023: 18.5%FY 2024: -718.2%FY 2025: 277.2%FY 2026: -186.8%
FY 2017 FY 2026
Free Cash Flow -73.0%
FY 2017: 23.2%FY 2018: -52.1%FY 2019: 43.3%FY 2020: 18.7%FY 2021: -42.4%FY 2022: -23.6%FY 2023: 7.9%FY 2024: 43.3%FY 2025: -38.4%FY 2026: -73.0%
FY 2017 FY 2026

Financial Health

Current Ratio 45.3×
FY 2017: 6.1×FY 2018: 2.0×FY 2019: 0.9×FY 2020: 1.0×FY 2021: 3.1×FY 2022: 121×FY 2023: 116×FY 2024: 6.8×FY 2025: 7.7×FY 2026: 45.3×
FY 2017 5y median 45.3× FY 2026
Quick Ratio 45.3×
FY 2017: 6.1×FY 2018: 2.0×FY 2019: 0.9×FY 2020: 1.0×FY 2021: 3.1×FY 2022: 121×FY 2023: 116×FY 2024: 6.8×FY 2025: 7.7×FY 2026: 45.3×
FY 2017 5y median 45.3× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 3.5×
FY 2017: -23728×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.2×FY 2021: 0.6×FY 2022: 20.1×FY 2023: 10.5×FY 2024: 7.7×FY 2025: 3.5×FY 2026: 3.5×
FY 2017 5y median 7.7× FY 2026
Interest Coverage 0.0×
FY 2017: -2886×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -8447×FY 2021: -1189×FY 2022: -8629×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 4.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 4.9%
FY 2017 5y median 0.0% FY 2026
Payout Ratio -1.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: -1.3%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-04-30